Financial Health Assessment: TAYNA LIMITED

📊 Financial Health Score: B+

Explanation: Tayna Limited demonstrates a fundamentally healthy business with consistent profitability and strong asset growth over its trading life. However, the 2024 accounts reveal concerning symptoms—declining revenue, significant liability growth, and cash contraction—that temper the overall assessment. Critically, the company has transferred its trade and assets to its parent entity and is now dormant, meaning this is effectively an "end-of-life" assessment for the trading entity.

1. Key Vital Signs

Revenue (Turnover)

Diagnosis: The 5.5% revenue decline in 2024 is a mild fever—concerning but not alarming for a business that achieved £25.5M the prior year. This could reflect normal market fluctuations in the battery retail sector or competitive pressure. However, it interrupts what had been a strong growth trajectory.

Net Assets (Shareholders' Funds)

Diagnosis: This is the patient's strongest vital sign. Net assets have grown nearly sixfold from £594K (2015) to £3.43M (2024)—a compound annual growth rate of approximately 21% over 9 years. The business has been consistently profitable and retaining earnings. This is the financial equivalent of a strong heartbeat.

Cash Position

Diagnosis: The cash position is volatile and has declined significantly from its 2023 peak. The drop from £1.44M to £869K warrants attention—this is like a patient whose blood pressure is fluctuating. However, given the company has transferred operations to its parent, this may reflect cash redistribution within the group structure.

Total Liabilities

Diagnosis: This is the most concerning symptom. Liabilities have surged by over 50% in a single year—from £3.65M to £5.5M—while revenue declined. This is the financial equivalent of rapid weight gain that could indicate an underlying condition. Without further detail on the composition of these liabilities (trade creditors, loans, group obligations), this warrants investigation.

Asset Base

Diagnosis: Asset growth of 39.2% is significant and appears healthy on the surface. However, when assets grow by £2.5M while liabilities grow by £1.85M, the net effect on equity is positive but raises questions about what is driving both increases. This may reflect inventory build-up, asset acquisitions, or group restructuring.

2. Diagnosis: What the Financial Data Reveals

Overall Financial Condition

Tayna Limited presents as a previously healthy patient undergoing a significant transition. The long-term trajectory is impressive:

• Consistent Profitability: Net assets have grown every year since 2018 (with one minor dip in 2017), demonstrating the business model works
• Strong Market Position: As an online battery retailer achieving £24M+ turnover, the company has established significant market presence
• Conservative Capital Structure: Share capital of only £100 means virtually all equity is retained earnings—a sign of genuine wealth creation rather than financial engineering

Symptoms of Current Concern

1. Revenue Contraction (-5.5%): While modest, this is the first decline after strong growth. The directors cite "rising costs" as the principal risk, suggesting margin pressure may be intensifying.

2. Liability Expansion (+50.6%): The dramatic increase in liabilities without proportional revenue growth is the financial equivalent of shortness of breath during exercise—it suggests the business is working harder to maintain position.

3. Cash Depletion (-39.5%): The drop from £1.44M to £869K cash, combined with rising liabilities, indicates potential cash flow stress.

4. Leverage Increasing: The debt-to-equity ratio has risen from 1.32 (2023) to 1.60 (2024), meaning liabilities now represent 160% of shareholders' funds compared to 132% previously.

The Critical Context: Group Restructuring

The most significant finding is buried in the strategic report: "On the 1 June 2025 the trade and assets of Tayna Limited were transferred to its parent company and at that date the company became dormant."

This means: - The trading business has been absorbed by Tayna Group Limited (the 75%+ shareholder) - Tayna Limited itself is now a dormant shell - The 2024 accounts represent the final year of independent trading - The liability increase and asset growth may reflect pre-transfer restructuring

This is analogous to a patient being transferred to a larger hospital—the individual entity may appear weaker, but the overall health of the business (now within the group) may be stronger.

3. Prognosis: Future Financial Outlook

For Tayna Limited as a standalone entity: The prognosis is terminal—the company is dormant and will no longer trade independently.

For the underlying business: The prognosis is cautiously positive: - The business generated consistent profits over 17+ years of trading - Net asset growth demonstrates a viable business model - The transfer to the parent company suggests group consolidation rather than business failure - No dividends were declared for 2024, suggesting cash retention for the transition

Key Risk Factors: - Rising costs (workforce and energy) identified by directors - The online retail sector remains competitive - The transition to the parent company must be managed carefully to preserve business value

4. Recommendations: Actions to Improve Financial Wellness

Given the company is now dormant, these recommendations apply to the continuing business under Tayna Group Limited:

Immediate Actions

1. Monitor the Transfer: Ensure all assets and liabilities have been properly transferred at fair value, and that the dormant company has no residual obligations that could create future liabilities for the group.

2. Cash Flow Management: The declining cash position in 2024 suggests the business was consuming more cash than it generated. The group should investigate whether this was a one-off related to restructuring or indicative of ongoing cash flow challenges.

3. Cost Control: With the directors identifying rising workforce and energy costs as principal risks, the group should implement rigorous cost monitoring and consider hedging strategies for energy costs.

Medium-Term Actions

4. Revenue Recovery: Investigate the 5.5% revenue decline—is this market-driven, competitive, or a result of operational changes? Understanding the root cause will inform strategy.

5. Liability Review: The 50% increase in liabilities requires explanation. The group should ensure this doesn't create undue leverage that constrains future operations.

6. Working Capital Optimization: The volatile cash position suggests working capital management needs attention. Consider inventory optimization, supplier payment terms, and debtor management.

Long-Term Actions

7. Strategic Investment: The automated pricing system mentioned in the strategic report is a positive step—continue investing in technology to maintain competitive advantage in online retail.

8. Succession Planning: With a director resignation noted (John Frederick Coombes resigned 31 December 2025), ensure appropriate governance continuity within the group structure.

Financial Health Summary